Dolby Laboratories SVP exercises 7,667 options

The sales were reported under a Rule 10b5-1 plan; post-transaction holdings included 103,190 shares underlying restricted stock units subject to forfeiture until vesting.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Dolby Laboratories, Inc. SVP, Entertainment John D. Couling exercised options for 7,667 Class A common shares on October 1, 2026, at a $45.50 exercise price, then sold 6,831 shares at a weighted average price of $58.7164 and 836 shares at a weighted average price of $59.3275. The sales were reported under a Rule 10b5-1 trading plan. The option had been granted for 46,000 shares and was fully vested and exercisable; post-transaction holdings included 103,190 shares underlying restricted stock units subject to forfeiture until vesting.

Insider Trade Summary 10b5-1

Exercise and Sale: 7,667 shares ($102K approx. pre-tax spread)

Exercise and Sale 4 txns

Insider Couling John D

Role SVP, Entertainment

Sold 7,667 shs ($451K)

Approx. gross sale proceeds $451K

Approx. exercise cost $349K

Approx. pre-tax spread $102K

Type	Security	Shares	Price	Value
Exercise	Employee Stock Option (Right to Buy) ^F4	7,667	$0.00	$0.00
Exercise	Class A Common Stock ^F1	7,667	$45.50	$349K
Sale	Class A Common Stock ^{F2, F1}	6,831	$58.7164	$401K
Sale	Class A Common Stock ^{F3, F1}	836	$59.3275	$50K

Holdings After Transaction: Employee Stock Option (Right to Buy) — 0 contracts (Direct); Class A Common Stock — 166,803 shares (Direct)

Footnotes (4)

F1. Shares held following the reported transactions include 103,190 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
F2. The shares were sold in multiple transactions at prices ranging from $58.275 to $59.255, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F3. The shares were sold in multiple transactions at prices ranging from $59.32 to $59.41, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F4. This option was granted for a total of 46,000 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date.

Key Figures

Options exercised: 7,667 shares Exercise price: $45.50 per share First sale: 6,831 shares +5 more

8 metrics

Options exercised 7,667 shares Class A common shares on October 1, 2026

Exercise price $45.50 per share Option exercise on October 1, 2026

First sale 6,831 shares Class A common shares sold on October 1, 2026

First weighted average sale price $58.7164 per share Sale of 6,831 shares on October 1, 2026

Second sale 836 shares Class A common shares sold on October 1, 2026

Second weighted average sale price $59.3275 per share Sale of 836 shares on October 1, 2026

Shares underlying restricted stock units 103,190 shares Subject to forfeiture until vesting

Original option grant 46,000 shares Class A common stock

Key Terms

Employee Stock Option (Right to Buy), Rule 10b5-1 trading plan, weighted average sale price, restricted stock units

4 terms

Employee Stock Option (Right to Buy) financial

"Employee Stock Option (Right to Buy)"

Rule 10b5-1 trading plan financial

"transactions affirmed under a trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sale price financial

"reflects the weighted average sale price"

restricted stock units financial

"shares underlying restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many DLB shares did John D. Couling sell and at what prices?

On October 1, 2026, John D. Couling sold 6,831 Class A shares at a weighted average price of $58.7164 and 836 shares at a weighted average price of $59.3275; the sales were reported under a Rule 10b5-1 trading plan.

What option exercise did DLB executive John D. Couling report?

On October 1, 2026, John D. Couling exercised options for 7,667 Class A common shares at an exercise price of $45.50. The option was fully vested and exercisable and had been granted for a total of 46,000 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 10/05/2026 - 08:43 PM Accepted by SEC EDGAR 10/05/2026 - 08:42 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Couling John D

(Last)

(First)

(Middle)

C/O DOLBY LABORATORIES, INC.

1275 MARKET STREET

(Street)

SAN FRANCISCO

CALIFORNIA

94103

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Dolby Laboratories, Inc. [ DLB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP, Entertainment

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	10/01/2026		M		7,667	A	$45.5	174,470⁽¹⁾	D
Class A Common Stock	10/01/2026		S		6,831	D	$58.7164⁽²⁾	167,639⁽¹⁾	D
Class A Common Stock	10/01/2026		S		836	D	$59.3275⁽³⁾	166,803⁽¹⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Employee Stock Option (Right to Buy)	$45.5	10/01/2026		M			7,667	⁽⁴⁾	12/15/2026	Class A Common Stock	7,667	$0	0	D

Explanation of Responses:

1. Shares held following the reported transactions include 103,190 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.

2. The shares were sold in multiple transactions at prices ranging from $58.275 to $59.255, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

3. The shares were sold in multiple transactions at prices ranging from $59.32 to $59.41, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

4. This option was granted for a total of 46,000 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date.

	/s/ Daniel Rodriguez as Attorney-in-Fact for John Couling	10/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR